Rationale – Exercise as Medicine

Table of Contents

  1. The Rationale – Why Exercise is Medicine
  2. Molecular Map of Endurance Training – Insights from MoTrPAC
  3. Leading Underlying Causes of Death – USA and Germany
  4. Implications for the Lecture Series

1 The Rationale – Why Exercise is Medicine

Opening Premise

Cardiologist and Stanford geneticist Euan Ashley has summarised contemporary evidence in a single line:

“Exercise may be the single most potent medical intervention ever known.” — Euan Ashley [1, 2]

This statement is not a rhetorical flourish. Across all-cause mortality, cardiometabolic disease, cancer, neurodegenerative disease, mental health, and immune function, regular physical activity produces effect sizes that rival — and in several disease domains exceed — those of standard pharmacological interventions [3, 4]. The clinical question of the 21st century is therefore not whether exercise should be prescribed, but how — that is, with which dose, in which population, at which point in the disease trajectory, and integrated with which other interventions.

Defining the Field

Sports medicine in the German-speaking academic tradition is positioned at the interface of internal medicine, physiology, immunology and behavioural science. It addresses:

  • the diagnostic characterisation of exercise capacity and physiological response patterns,
  • the prescriptive translation of exercise dose into therapeutic effect,
  • the preventive application of physical activity across the life course, and
  • the rehabilitative use of structured movement in chronic disease management.

This lecture series — Medicine in Sports and Exercise — is built around the second and third of these pillars: how the underlying biology of exercise translates into effective, individualised prescription in healthy individuals and in patients with chronic non-communicable disease.

Why Now

Three developments justify revisiting exercise medicine in 2026:

  1. Molecular resolution. Multi-omic profiling now resolves the temporal cascade of exercise-induced adaptation across nearly every tissue and platform — see Section 2 [5].
  2. Disease burden. Non-communicable diseases — cardiovascular disease, cancer, diabetes, neurodegenerative illness, infection-associated chronic illness — dominate mortality in industrialised countries — see Section 3.
  3. Inactivity epidemic. Roughly 31 % of the adult world population (≈1.8 billion people) fail to meet WHO physical activity recommendations, and the projected cost to global public health systems between 2020 and 2030 is approximately USD 300 billion (≈USD 27 billion per year) [6, 7].

2 Molecular Map of Endurance Training – Insights from MoTrPAC

The MoTrPAC Initiative

The Molecular Transducers of Physical Activity Consortium (MoTrPAC) was established to build a comprehensive molecular map of the systemic effects of exercise across tissues, time points, sexes and omic platforms [5]. Their 2024 Nature publication reports the first whole-organism temporal multi-omic atlas of endurance training.

Study Design

Six-month-old male and female Fischer 344 rats were subjected to progressive treadmill endurance training for 1, 2, 4 or 8 weeks, with tissues collected 48 h after the last bout. Sex-matched sedentary controls were used as the comparator group.

ParameterOutcome at 8 weeks
Aerobic capacity (V̇O₂max)+18 % (males) / +16 % (females)
Body fat percentage−5 % (males); unchanged in females, but +4 % in sedentary controls
Lean massNo significant change

Table 1. Phenotypic adaptations to 8 weeks of progressive endurance training in rats [5].

Scope of the Multi-Omic Atlas

The compendium spans:

  • 9,466 assays across 19 tissues, 25 molecular platforms, and 4 training time points;
  • whole blood, plasma, and 18 solid tissues profiled by transcriptomics, proteomics, metabolomics, lipidomics, phospho-/acetyl-/ubiquitylproteomics, epigenomics and immunoassays;
  • 681,256 non-epigenetic and 14,334,496 epigenetic measurements;
  • 213,689 non-epigenetic and 2,799,307 epigenetic unique features.

Key Biological Insights

The temporal analyses revealed expansive, widespread regulation of immune, metabolic, stress-response and mitochondrial pathways, with substantial sex differences in multiple tissues. Many of the identified molecular alterations map onto human disease processes:

  • non-alcoholic / metabolic-associated fatty liver disease (NAFLD / MAFLD),
  • inflammatory bowel disease (IBD),
  • cardiovascular health,
  • tissue injury and recovery.

Practical insight. MoTrPAC reframes exercise not as a single physiological stressor but as a coordinated, multi-tissue, multi-omic perturbation. Effective exercise prescription must therefore consider tissue-, sex- and time-specific response windows — themes that recur throughout this lecture series.


3 Leading Underlying Causes of Death – USA and Germany

United States (CDC, MMWR 2024)

The CDC’s Morbidity and Mortality Weekly Report lists the leading underlying causes of death for the United States [8]. Two of the top causes — heart disease and malignant neoplasms (cancer) — are amenable to substantial modification through regular physical activity. Additional top-ten causes that respond to physical activity intervention include:

  • chronic lower respiratory diseases,
  • cerebrovascular disease (stroke),
  • diabetes mellitus,
  • Alzheimer disease and related dementias.

Germany (Destatis)

The German Federal Statistical Office reports a similar top-cause profile: cardiovascular disease, malignant neoplasms, dementia, diabetes, and respiratory illness dominate [9]. Across both populations, the most lethal conditions are precisely those for which exercise has the strongest, most reproducible therapeutic evidence.

Why This Pattern Matters

A clinician who prescribes exercise is, in epidemiological terms, addressing the largest single modifiable contributor to the population mortality table. This is the empirical basis for the Ashley statement quoted in Section 1 [1, 2].


4 Implications for the Lecture Series

This first lecture sets the agenda. The remaining eleven lectures follow the logic that:

  • Exercise is a coordinated multi-organ stimulus (Lectures 2–3) — circadian and sleep biology, exerkines, IL-6 as an energy allocator.
  • Inactivity drives the dominant chronic diseases (Lectures 4–5) — prediabetes, type 2 diabetes, the metabolic syndrome.
  • Exercise is dosable and prescribable (Lectures 6–7) — exercise snacks, structured prescriptions using % HRR, % HRmax, RPE and MET.
  • Exercise has anti-inflammatory and disease-modifying effects in major chronic illnesses (Lectures 8–11) — pro- and anti-inflammatory effects, MAFLD, IBD, and the corresponding prescription frameworks.
  • Exerkines unify the picture (Lecture 12) — an inter-organ signalling system that translates muscle contraction into systemic medicine.

Practical insight. Treat Lecture 1 as the conceptual frame. Each subsequent lecture re-enters this frame from a different organ system or disease perspective. The empirical anchor — Ashley’s quote, MoTrPAC, and the leading-cause-of-death tables — is the same throughout.


References

  • [1] Topol E. Evan Ashley: Exercise may be the single most potent medical intervention ever known. https://erictopol.substack.com/p/evan-ashley-exercise-may-be-the-single
  • [2] Nature Collections. Exercise as Medicine. https://www.nature.com/collections/ciibcebh
  • [3] Pedersen BK, Saltin B. Exercise as medicine — evidence for prescribing exercise as therapy in 26 different chronic diseases. Scandinavian Journal of Medicine & Science in Sports. 2015;25(S3):1–72. doi:10.1111/sms.12581.
  • [4] Naci H, Ioannidis JPA. Comparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological study. BMJ. 2013;347:f5577. doi:10.1136/bmj.f5577.
  • [5] MoTrPAC Study Group. Temporal dynamics of the multi-omic response to endurance exercise training. Nature. 2024;629:174–183. doi:10.1038/s41586-023-06877-w.
  • [6] Strain T, Flaxman S, Guthold R, Semenova E, Cowan M, Riley LM, Bull FC, Stevens GA, Country Data Author Group. National, regional, and global trends in insufficient physical activity among adults: a pooled analysis of 507 population-based surveys with 5·7 million participants. Lancet Global Health. 2024;12(8):e1232–e1243. doi:10.1016/S2214-109X(24)00150-5.
  • [7] World Health Organization. Physical activity fact sheet. 26 June 2024.
  • [8] Centers for Disease Control and Prevention. Leading underlying causes of death — United States. MMWR. https://www.cdc.gov/mmwr/volumes/73/wr/mm7331a1.htm
  • [9] Statistisches Bundesamt (Destatis). Todesursachen in Deutschland. https://www.destatis.de/DE/Themen/Gesellschaft-Umwelt/Gesundheit/Todesursachen/_inhalt.html
  • [10] Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee IM, Nieman DC, Swain DP; American College of Sports Medicine. ACSM position stand: quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults — guidance for prescribing exercise. Medicine & Science in Sports & Exercise. 2011;43(7):1334–1359.

One-Minute-Paper Topics

A One-Minute-Paper (OMP) is a short, focused prompt that students answer in ~60 seconds at the end of a session to consolidate learning, surface misconceptions, and provide formative feedback. When answering, be concise, specific, and use terminology from today’s session.

  1. Restate the Ashley premise — “Exercise may be the single most potent medical intervention ever known” — in your own words. Which categories of evidence (mortality, disease incidence, biomarkers) would you need to defend or challenge it?
  2. Name the four functional pillars of sports medicine introduced in Section 1 and give one practical example of each.
  3. Summarise the MoTrPAC study design in three sentences: species, intervention, time points, and the comparator group.
  4. List the eight omic platforms used in MoTrPAC. Why is a multi-omic approach necessary rather than a single transcriptomic readout?
  5. The MoTrPAC dataset spans 211 combinations of tissues and platforms. What does this scale enable that a single-tissue, single-platform study cannot?
  6. Reproduce Table 1 from memory (V̇O₂max change, body fat change, lean mass change). What sex differences did the study report after 8 weeks?
  7. Define “exerkine” in one sentence (anticipating Lecture 3). Which MoTrPAC tissues would you expect to be the dominant exerkine sources?
  8. List the top five leading causes of death in the United States and in Germany. Which of them are evidence-graded as responsive to regular physical activity?
  9. Approximately 31 % of adults globally fail to meet physical activity recommendations. What are the two WHO-recommended weekly minima (moderate vs. vigorous)?
  10. What is the projected 2020–2030 global cost of physical inactivity? How would you communicate this number to a policy audience?
  11. Why does this lecture frame “non-communicable diseases” rather than “lifestyle diseases”? What is the clinical and political weight of the chosen terminology?
  12. Distinguish between acute and chronic responses to exercise. Which of the two is captured by MoTrPAC’s 48-hour post-training sampling design?
  13. Sex differences appeared in multiple MoTrPAC tissues. Name two physiological mechanisms (hormonal, mitochondrial, immune) that could plausibly underlie these differences.
  14. The MoTrPAC findings map onto NAFLD/MAFLD, IBD and cardiovascular disease. Which of these will Lectures 9–11 of this course address in detail?
  15. Why is “tissue, time and sex” — rather than a single dose — the proper framing for exercise prescription based on MoTrPAC’s findings?
  16. The lecture argues that the most lethal chronic diseases are precisely those most responsive to exercise. What public-health intervention strategy follows from this convergence?
  17. Sketch the conceptual frame of this lecture series in five lines: stimulus → mediators → disease targets → prescription → unifying biology.
  18. Identify two limitations of using rodent multi-omic data to inform human exercise prescription. How does MoTrPAC plan to address them?
  19. Compare physical activity (movement) with exercise (planned, structured, repetitive). Which of the two does MoTrPAC operationalise, and why does the distinction matter for clinical translation?
  20. Imagine a 55-year-old patient with prediabetes, hepatic steatosis and mild depression. Using only the framework of Lecture 1, justify in three sentences why exercise should be considered a first-line intervention rather than an adjunct.